Global Generic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 146

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Generic Drugs market size was valued at USD 322540 million in 2023 and is forecast to a readjusted size of USD 550750 million by 2030 with a CAGR of 7.9% during review period.

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.

North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.

The Global Info Research report includes an overview of the development of the Generic Drugs industry chain, the market status of Hospital Pharmacy (Oral, Injection), Retail Pharmacy (Oral, Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Generic Drugs.

Regionally, the report analyzes the Generic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Generic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Generic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Generic Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Injection).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Generic Drugs market.

Regional Analysis: The report involves examining the Generic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Generic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Generic Drugs:
Company Analysis: Report covers individual Generic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Generic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Retail Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Generic Drugs. It assesses the current state, advancements, and potential future developments in Generic Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Generic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Generic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Oral
Injection
Other

Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Other

Market segment by players, this report covers
Teva
Novartis
Viatris
Sun Pharmaceutical
Aspen Pharmacare
Fresenius Kabi
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO
Stada Arzneimittel
Bausch Health
Hikma
Torrent
Glenmark
Piramal Pharma
Sawai Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Generic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Generic Drugs, with revenue, gross margin and global market share of Generic Drugs from 2019 to 2024.
Chapter 3, the Generic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Generic Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Generic Drugs.
Chapter 13, to describe Generic Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Generic Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Generic Drugs by Type
        1.3.1 Overview: Global Generic Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Generic Drugs Consumption Value Market Share by Type in 2023
        1.3.3 Oral
        1.3.4 Injection
        1.3.5 Other
    1.4 Global Generic Drugs Market by Application
        1.4.1 Overview: Global Generic Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital Pharmacy
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Generic Drugs Market Size & Forecast
    1.6 Global Generic Drugs Market Size and Forecast by Region
        1.6.1 Global Generic Drugs Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Generic Drugs Market Size by Region, (2019-2030)
        1.6.3 North America Generic Drugs Market Size and Prospect (2019-2030)
        1.6.4 Europe Generic Drugs Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Generic Drugs Market Size and Prospect (2019-2030)
        1.6.6 South America Generic Drugs Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Generic Drugs Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Teva
        2.1.1 Teva Details
        2.1.2 Teva Major Business
        2.1.3 Teva Generic Drugs Product and Solutions
        2.1.4 Teva Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Teva Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Generic Drugs Product and Solutions
        2.2.4 Novartis Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Viatris
        2.3.1 Viatris Details
        2.3.2 Viatris Major Business
        2.3.3 Viatris Generic Drugs Product and Solutions
        2.3.4 Viatris Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Viatris Recent Developments and Future Plans
    2.4 Sun Pharmaceutical
        2.4.1 Sun Pharmaceutical Details
        2.4.2 Sun Pharmaceutical Major Business
        2.4.3 Sun Pharmaceutical Generic Drugs Product and Solutions
        2.4.4 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
    2.5 Aspen Pharmacare
        2.5.1 Aspen Pharmacare Details
        2.5.2 Aspen Pharmacare Major Business
        2.5.3 Aspen Pharmacare Generic Drugs Product and Solutions
        2.5.4 Aspen Pharmacare Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Aspen Pharmacare Recent Developments and Future Plans
    2.6 Fresenius Kabi
        2.6.1 Fresenius Kabi Details
        2.6.2 Fresenius Kabi Major Business
        2.6.3 Fresenius Kabi Generic Drugs Product and Solutions
        2.6.4 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Fresenius Kabi Recent Developments and Future Plans
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Generic Drugs Product and Solutions
        2.7.4 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Sanofi Recent Developments and Future Plans
    2.8 Aurobindo
        2.8.1 Aurobindo Details
        2.8.2 Aurobindo Major Business
        2.8.3 Aurobindo Generic Drugs Product and Solutions
        2.8.4 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Aurobindo Recent Developments and Future Plans
    2.9 Lupin
        2.9.1 Lupin Details
        2.9.2 Lupin Major Business
        2.9.3 Lupin Generic Drugs Product and Solutions
        2.9.4 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Lupin Recent Developments and Future Plans
    2.10 Dr. Reddy's
        2.10.1 Dr. Reddy's Details
        2.10.2 Dr. Reddy's Major Business
        2.10.3 Dr. Reddy's Generic Drugs Product and Solutions
        2.10.4 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Dr. Reddy's Recent Developments and Future Plans
    2.11 Apotex
        2.11.1 Apotex Details
        2.11.2 Apotex Major Business
        2.11.3 Apotex Generic Drugs Product and Solutions
        2.11.4 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Apotex Recent Developments and Future Plans
    2.12 Cipla
        2.12.1 Cipla Details
        2.12.2 Cipla Major Business
        2.12.3 Cipla Generic Drugs Product and Solutions
        2.12.4 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Cipla Recent Developments and Future Plans
    2.13 ENDO
        2.13.1 ENDO Details
        2.13.2 ENDO Major Business
        2.13.3 ENDO Generic Drugs Product and Solutions
        2.13.4 ENDO Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 ENDO Recent Developments and Future Plans
    2.14 Stada Arzneimittel
        2.14.1 Stada Arzneimittel Details
        2.14.2 Stada Arzneimittel Major Business
        2.14.3 Stada Arzneimittel Generic Drugs Product and Solutions
        2.14.4 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Stada Arzneimittel Recent Developments and Future Plans
    2.15 Bausch Health
        2.15.1 Bausch Health Details
        2.15.2 Bausch Health Major Business
        2.15.3 Bausch Health Generic Drugs Product and Solutions
        2.15.4 Bausch Health Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Bausch Health Recent Developments and Future Plans
    2.16 Hikma
        2.16.1 Hikma Details
        2.16.2 Hikma Major Business
        2.16.3 Hikma Generic Drugs Product and Solutions
        2.16.4 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Hikma Recent Developments and Future Plans
    2.17 Torrent
        2.17.1 Torrent Details
        2.17.2 Torrent Major Business
        2.17.3 Torrent Generic Drugs Product and Solutions
        2.17.4 Torrent Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Torrent Recent Developments and Future Plans
    2.18 Glenmark
        2.18.1 Glenmark Details
        2.18.2 Glenmark Major Business
        2.18.3 Glenmark Generic Drugs Product and Solutions
        2.18.4 Glenmark Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Glenmark Recent Developments and Future Plans
    2.19 Piramal Pharma
        2.19.1 Piramal Pharma Details
        2.19.2 Piramal Pharma Major Business
        2.19.3 Piramal Pharma Generic Drugs Product and Solutions
        2.19.4 Piramal Pharma Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 Piramal Pharma Recent Developments and Future Plans
    2.20 Sawai Pharmaceutical
        2.20.1 Sawai Pharmaceutical Details
        2.20.2 Sawai Pharmaceutical Major Business
        2.20.3 Sawai Pharmaceutical Generic Drugs Product and Solutions
        2.20.4 Sawai Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.20.5 Sawai Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Generic Drugs Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Generic Drugs by Company Revenue
        3.2.2 Top 3 Generic Drugs Players Market Share in 2023
        3.2.3 Top 6 Generic Drugs Players Market Share in 2023
    3.3 Generic Drugs Market: Overall Company Footprint Analysis
        3.3.1 Generic Drugs Market: Region Footprint
        3.3.2 Generic Drugs Market: Company Product Type Footprint
        3.3.3 Generic Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Generic Drugs Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Generic Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Generic Drugs Consumption Value Market Share by Application (2019-2024)
    5.2 Global Generic Drugs Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Generic Drugs Consumption Value by Type (2019-2030)
    6.2 North America Generic Drugs Consumption Value by Application (2019-2030)
    6.3 North America Generic Drugs Market Size by Country
        6.3.1 North America Generic Drugs Consumption Value by Country (2019-2030)
        6.3.2 United States Generic Drugs Market Size and Forecast (2019-2030)
        6.3.3 Canada Generic Drugs Market Size and Forecast (2019-2030)
        6.3.4 Mexico Generic Drugs Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Generic Drugs Consumption Value by Type (2019-2030)
    7.2 Europe Generic Drugs Consumption Value by Application (2019-2030)
    7.3 Europe Generic Drugs Market Size by Country
        7.3.1 Europe Generic Drugs Consumption Value by Country (2019-2030)
        7.3.2 Germany Generic Drugs Market Size and Forecast (2019-2030)
        7.3.3 France Generic Drugs Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Generic Drugs Market Size and Forecast (2019-2030)
        7.3.5 Russia Generic Drugs Market Size and Forecast (2019-2030)
        7.3.6 Italy Generic Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Generic Drugs Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Generic Drugs Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Generic Drugs Market Size by Region
        8.3.1 Asia-Pacific Generic Drugs Consumption Value by Region (2019-2030)
        8.3.2 China Generic Drugs Market Size and Forecast (2019-2030)
        8.3.3 Japan Generic Drugs Market Size and Forecast (2019-2030)
        8.3.4 South Korea Generic Drugs Market Size and Forecast (2019-2030)
        8.3.5 India Generic Drugs Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Generic Drugs Market Size and Forecast (2019-2030)
        8.3.7 Australia Generic Drugs Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Generic Drugs Consumption Value by Type (2019-2030)
    9.2 South America Generic Drugs Consumption Value by Application (2019-2030)
    9.3 South America Generic Drugs Market Size by Country
        9.3.1 South America Generic Drugs Consumption Value by Country (2019-2030)
        9.3.2 Brazil Generic Drugs Market Size and Forecast (2019-2030)
        9.3.3 Argentina Generic Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Generic Drugs Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Generic Drugs Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Generic Drugs Market Size by Country
        10.3.1 Middle East & Africa Generic Drugs Consumption Value by Country (2019-2030)
        10.3.2 Turkey Generic Drugs Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Generic Drugs Market Size and Forecast (2019-2030)
        10.3.4 UAE Generic Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Generic Drugs Market Drivers
    11.2 Generic Drugs Market Restraints
    11.3 Generic Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Generic Drugs Industry Chain
    12.2 Generic Drugs Upstream Analysis
    12.3 Generic Drugs Midstream Analysis
    12.4 Generic Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Generic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Generic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Generic Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Generic Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Teva Company Information, Head Office, and Major Competitors
    Table 6. Teva Major Business
    Table 7. Teva Generic Drugs Product and Solutions
    Table 8. Teva Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Teva Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Generic Drugs Product and Solutions
    Table 13. Novartis Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Viatris Company Information, Head Office, and Major Competitors
    Table 16. Viatris Major Business
    Table 17. Viatris Generic Drugs Product and Solutions
    Table 18. Viatris Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Viatris Recent Developments and Future Plans
    Table 20. Sun Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 21. Sun Pharmaceutical Major Business
    Table 22. Sun Pharmaceutical Generic Drugs Product and Solutions
    Table 23. Sun Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Sun Pharmaceutical Recent Developments and Future Plans
    Table 25. Aspen Pharmacare Company Information, Head Office, and Major Competitors
    Table 26. Aspen Pharmacare Major Business
    Table 27. Aspen Pharmacare Generic Drugs Product and Solutions
    Table 28. Aspen Pharmacare Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Aspen Pharmacare Recent Developments and Future Plans
    Table 30. Fresenius Kabi Company Information, Head Office, and Major Competitors
    Table 31. Fresenius Kabi Major Business
    Table 32. Fresenius Kabi Generic Drugs Product and Solutions
    Table 33. Fresenius Kabi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Fresenius Kabi Recent Developments and Future Plans
    Table 35. Sanofi Company Information, Head Office, and Major Competitors
    Table 36. Sanofi Major Business
    Table 37. Sanofi Generic Drugs Product and Solutions
    Table 38. Sanofi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Sanofi Recent Developments and Future Plans
    Table 40. Aurobindo Company Information, Head Office, and Major Competitors
    Table 41. Aurobindo Major Business
    Table 42. Aurobindo Generic Drugs Product and Solutions
    Table 43. Aurobindo Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Aurobindo Recent Developments and Future Plans
    Table 45. Lupin Company Information, Head Office, and Major Competitors
    Table 46. Lupin Major Business
    Table 47. Lupin Generic Drugs Product and Solutions
    Table 48. Lupin Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Lupin Recent Developments and Future Plans
    Table 50. Dr. Reddy's Company Information, Head Office, and Major Competitors
    Table 51. Dr. Reddy's Major Business
    Table 52. Dr. Reddy's Generic Drugs Product and Solutions
    Table 53. Dr. Reddy's Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Dr. Reddy's Recent Developments and Future Plans
    Table 55. Apotex Company Information, Head Office, and Major Competitors
    Table 56. Apotex Major Business
    Table 57. Apotex Generic Drugs Product and Solutions
    Table 58. Apotex Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Apotex Recent Developments and Future Plans
    Table 60. Cipla Company Information, Head Office, and Major Competitors
    Table 61. Cipla Major Business
    Table 62. Cipla Generic Drugs Product and Solutions
    Table 63. Cipla Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Cipla Recent Developments and Future Plans
    Table 65. ENDO Company Information, Head Office, and Major Competitors
    Table 66. ENDO Major Business
    Table 67. ENDO Generic Drugs Product and Solutions
    Table 68. ENDO Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. ENDO Recent Developments and Future Plans
    Table 70. Stada Arzneimittel Company Information, Head Office, and Major Competitors
    Table 71. Stada Arzneimittel Major Business
    Table 72. Stada Arzneimittel Generic Drugs Product and Solutions
    Table 73. Stada Arzneimittel Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Stada Arzneimittel Recent Developments and Future Plans
    Table 75. Bausch Health Company Information, Head Office, and Major Competitors
    Table 76. Bausch Health Major Business
    Table 77. Bausch Health Generic Drugs Product and Solutions
    Table 78. Bausch Health Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. Bausch Health Recent Developments and Future Plans
    Table 80. Hikma Company Information, Head Office, and Major Competitors
    Table 81. Hikma Major Business
    Table 82. Hikma Generic Drugs Product and Solutions
    Table 83. Hikma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 84. Hikma Recent Developments and Future Plans
    Table 85. Torrent Company Information, Head Office, and Major Competitors
    Table 86. Torrent Major Business
    Table 87. Torrent Generic Drugs Product and Solutions
    Table 88. Torrent Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Torrent Recent Developments and Future Plans
    Table 90. Glenmark Company Information, Head Office, and Major Competitors
    Table 91. Glenmark Major Business
    Table 92. Glenmark Generic Drugs Product and Solutions
    Table 93. Glenmark Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 94. Glenmark Recent Developments and Future Plans
    Table 95. Piramal Pharma Company Information, Head Office, and Major Competitors
    Table 96. Piramal Pharma Major Business
    Table 97. Piramal Pharma Generic Drugs Product and Solutions
    Table 98. Piramal Pharma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 99. Piramal Pharma Recent Developments and Future Plans
    Table 100. Sawai Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 101. Sawai Pharmaceutical Major Business
    Table 102. Sawai Pharmaceutical Generic Drugs Product and Solutions
    Table 103. Sawai Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 104. Sawai Pharmaceutical Recent Developments and Future Plans
    Table 105. Global Generic Drugs Revenue (USD Million) by Players (2019-2024)
    Table 106. Global Generic Drugs Revenue Share by Players (2019-2024)
    Table 107. Breakdown of Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 108. Market Position of Players in Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 109. Head Office of Key Generic Drugs Players
    Table 110. Generic Drugs Market: Company Product Type Footprint
    Table 111. Generic Drugs Market: Company Product Application Footprint
    Table 112. Generic Drugs New Market Entrants and Barriers to Market Entry
    Table 113. Generic Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 114. Global Generic Drugs Consumption Value (USD Million) by Type (2019-2024)
    Table 115. Global Generic Drugs Consumption Value Share by Type (2019-2024)
    Table 116. Global Generic Drugs Consumption Value Forecast by Type (2025-2030)
    Table 117. Global Generic Drugs Consumption Value by Application (2019-2024)
    Table 118. Global Generic Drugs Consumption Value Forecast by Application (2025-2030)
    Table 119. North America Generic Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 120. North America Generic Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 121. North America Generic Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 122. North America Generic Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 123. North America Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 124. North America Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 125. Europe Generic Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 126. Europe Generic Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 127. Europe Generic Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 128. Europe Generic Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 129. Europe Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 130. Europe Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 131. Asia-Pacific Generic Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 132. Asia-Pacific Generic Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 133. Asia-Pacific Generic Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 134. Asia-Pacific Generic Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 135. Asia-Pacific Generic Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 136. Asia-Pacific Generic Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 137. South America Generic Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 138. South America Generic Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 139. South America Generic Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 140. South America Generic Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 141. South America Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 142. South America Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 143. Middle East & Africa Generic Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 144. Middle East & Africa Generic Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 145. Middle East & Africa Generic Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 146. Middle East & Africa Generic Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 147. Middle East & Africa Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 148. Middle East & Africa Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 149. Generic Drugs Raw Material
    Table 150. Key Suppliers of Generic Drugs Raw Materials
List of Figures
    Figure 1. Generic Drugs Picture
    Figure 2. Global Generic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Generic Drugs Consumption Value Market Share by Type in 2023
    Figure 4. Oral
    Figure 5. Injection
    Figure 6. Other
    Figure 7. Global Generic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Generic Drugs Consumption Value Market Share by Application in 2023
    Figure 9. Hospital Pharmacy Picture
    Figure 10. Retail Pharmacy Picture
    Figure 11. Other Picture
    Figure 12. Global Generic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Generic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Generic Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Generic Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Generic Drugs Consumption Value Market Share by Region in 2023
    Figure 17. North America Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Generic Drugs Revenue Share by Players in 2023
    Figure 23. Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Generic Drugs Market Share in 2023
    Figure 25. Global Top 6 Players Generic Drugs Market Share in 2023
    Figure 26. Global Generic Drugs Consumption Value Share by Type (2019-2024)
    Figure 27. Global Generic Drugs Market Share Forecast by Type (2025-2030)
    Figure 28. Global Generic Drugs Consumption Value Share by Application (2019-2024)
    Figure 29. Global Generic Drugs Market Share Forecast by Application (2025-2030)
    Figure 30. North America Generic Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Generic Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Generic Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Generic Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Generic Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Generic Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Generic Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Generic Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Generic Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Generic Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Generic Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Generic Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Generic Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Generic Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Generic Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Generic Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 64. Generic Drugs Market Drivers
    Figure 65. Generic Drugs Market Restraints
    Figure 66. Generic Drugs Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Generic Drugs in 2023
    Figure 69. Manufacturing Process Analysis of Generic Drugs
    Figure 70. Generic Drugs Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Teva
Novartis
Viatris
Sun Pharmaceutical
Aspen Pharmacare
Fresenius Kabi
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO
Stada Arzneimittel
Bausch Health
Hikma
Torrent
Glenmark
Piramal Pharma
Sawai Pharmaceutical

Related Reports

Global Generic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Generic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 20 Jul 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Generic Drugs market size was valued at USD 322540 million in 2022 and is forecast to a readjusted size of USD 550750 million by 2029 with a CAGR of 7.9% during review period.

Global Generic Drugs Supply, Demand and Key Producers, 2023-2029

Global Generic Drugs Supply, Demand and Key Producers, 2023-2029

date 20 Jul 2023

date Pharma & Healthcare

The global Generic Drugs market size is expected to reach $ 550750 million by 2029, rising at a market growth of 7.9% CAGR during the forecast period (2023-2029).

Global Generic Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Generic Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031

date 08 Jan 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Generic Drugs market size was valued at US$ 377860 million in 2024 and is forecast to a readjusted size of USD 648170 million by 2031 with a CAGR of 8.1% during review period.

Product Tags

Inhalation & Nasal Spray Generic Drugs

Generic Drugs

Dolutegravir and Dolutegravir Generic Drugs

Dabigatran & Dabigatran Generic Drugs

Inhalation and Nasal Sprays Generic Drugs

Super Generic Drugs

Breast Cancer Generic Drugs

Generic Drugs for Multiple Cancers

Inhalation and Nasal Spray Generic Drugs

Chemical Generic Drugs

Inhaled Generic Drugs

Orally Inhaled Generic Drugs

Edoxaban Tosilate Tablets and Generic Drugs

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>